Naltrexone as Adjunct in Alcoholic Cocaine Dependent Patients - 4
Sponsor
National Institute on Drug Abuse (NIDA) (NIH)
Overall Status
Completed
CT.gov ID
NCT00000307
Collaborator
University of Texas (Other)
0
1
48
0
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate naltrexone as an adjunct in alcoholic cocaine dependent patients; concurrent relapse prevention theory.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
| Phase 2 |
Study Design
Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
Naltrexone as an Adjunct in Alcoholic Cocaine Dependent Patients
Study Start Date
:
Apr 1, 2003
Actual Primary Completion Date
:
Apr 1, 2007
Actual Study Completion Date
:
Apr 1, 2007
Outcome Measures
Primary Outcome Measures
- Verified abstinence from cocaine [over the 12 weeks of study]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
to 50 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Please contact site for information.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | University of Texas Health Science Center | Houston | Texas | United States | 77225 |
Sponsors and Collaborators
- National Institute on Drug Abuse (NIDA)
- University of Texas
Investigators
- Principal Investigator: John Grabowski, Ph.D., University of Texas
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
,
,
ClinicalTrials.gov Identifier:
NCT00000307
Other Study ID Numbers:
- NIDA-09262-4
- P50-09262-4
First Posted:
Sep 21, 1999
Last Update Posted:
Jan 12, 2017
Last Verified:
Oct 1, 2016
Keywords provided by ,
,
Additional relevant MeSH terms: